Visfatin: a new player in mesangial cell physiology and diabetic nephropathy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Song, Hye Kyoung | - |
dc.contributor.author | Lee, Mi Hwa | - |
dc.contributor.author | Kim, Bo Kyung | - |
dc.contributor.author | Park, Yun Gyu | - |
dc.contributor.author | Ko, Gang Jee | - |
dc.contributor.author | Kang, Young Sun | - |
dc.contributor.author | Han, Jee Young | - |
dc.contributor.author | Han, Sang Youb | - |
dc.contributor.author | Han, Kum Hyun | - |
dc.contributor.author | Kim, Hyoung Kyu | - |
dc.contributor.author | Cha, Dae Ryong | - |
dc.date.accessioned | 2021-09-09T02:50:50Z | - |
dc.date.available | 2021-09-09T02:50:50Z | - |
dc.date.created | 2021-06-10 | - |
dc.date.issued | 2008-11 | - |
dc.identifier.issn | 1931-857X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/122428 | - |
dc.description.abstract | Song HK, Lee MH, Kim BK, Park YG, Ko GJ, Kang YS, Han JY, Han SY, Han KH, Kim HK, Cha DR. Visfatin: a new player in mesangial cell physiology and diabetic nephropathy. Am J Physiol Renal Physiol 295: F1485-F1494, 2008. First published September 3, 2008; doi:10.1152/ajprenal.90231.2008. -Visfatin is an adipocytokine that improves insulin resistance and has an antidiabetic effect. However, the role of visfatin in the kidney has not yet been reported. In this experiment, the synthesis and physiological action of visfatin in cultured mesangial cells (MCs) were studied to investigate the role of visfatin in diabetic nephropathy. Visfatin was found synthesized in MCs as well as adipocytes. Visfatin synthesis was markedly increased, not by angiotensin II, but by high glucose stimuli. In addition, visfatin treatment induced a rapid uptake of glucose, peaking at 20 min after visfatin treatment in a dose-dependent manner. A small inhibiting RNA against insulin receptor significantly blocked visfatin-mediated glucose uptake. Visfatin stimuli also enhanced intracellular NAD levels, and treatment with FK866, which is a specific inhibitor of nicotinamide phosphoribosyltransferase (Nampt), significantly inhibited visfatin-induced NAD synthesis and glucose uptake. Visfatin treatment increased glucose transporter-1 (GLUT-1) protein expression in isolated cellular membranes, and pretreatment with cytochalasin B completely inhibited visfatin-induced glucose uptake. Moreover, immunofluorescent microscopy showed the migration of cytosolic GLUT-1 into cellular membranes after visfatin treatment. In accordance with these results, the activation of protein kinase B was detected after visfatin treatment. Furthermore, visfatin treatment dramatically increased the synthesis of profibrotic molecules including transforming growth factor-beta 1, plasminogen activator inhibitor-1, and type I collagen, and pretreatment with cytochalasin B completely inhibited visfatin-induced upregulation of profibrotic molecules. These results suggest that visfatin is produced in MCs, which are a novel target for visfatin, and play an important role in the pathogenesis of diabetic nephropathy. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | AMER PHYSIOLOGICAL SOC | - |
dc.subject | PROTEIN-KINASE-C | - |
dc.subject | COLONY-ENHANCING FACTOR | - |
dc.subject | HIGH-GLUCOSE MEDIUM | - |
dc.subject | PLASMA VISFATIN | - |
dc.subject | INSULIN-RESISTANCE | - |
dc.subject | ADIPOSE-TISSUE | - |
dc.subject | MESSENGER-RNA | - |
dc.subject | VISCERAL FAT | - |
dc.subject | RAT | - |
dc.subject | EXPRESSION | - |
dc.title | Visfatin: a new player in mesangial cell physiology and diabetic nephropathy | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Yun Gyu | - |
dc.contributor.affiliatedAuthor | Ko, Gang Jee | - |
dc.contributor.affiliatedAuthor | Kang, Young Sun | - |
dc.contributor.affiliatedAuthor | Kim, Hyoung Kyu | - |
dc.contributor.affiliatedAuthor | Cha, Dae Ryong | - |
dc.identifier.doi | 10.1152/ajprenal.90231.2008 | - |
dc.identifier.scopusid | 2-s2.0-57349120067 | - |
dc.identifier.wosid | 000260674800026 | - |
dc.identifier.bibliographicCitation | AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, v.295, no.5, pp.F1485 - F1494 | - |
dc.relation.isPartOf | AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY | - |
dc.citation.title | AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY | - |
dc.citation.volume | 295 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | F1485 | - |
dc.citation.endPage | F1494 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Physiology | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Physiology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.subject.keywordPlus | PROTEIN-KINASE-C | - |
dc.subject.keywordPlus | COLONY-ENHANCING FACTOR | - |
dc.subject.keywordPlus | HIGH-GLUCOSE MEDIUM | - |
dc.subject.keywordPlus | PLASMA VISFATIN | - |
dc.subject.keywordPlus | INSULIN-RESISTANCE | - |
dc.subject.keywordPlus | ADIPOSE-TISSUE | - |
dc.subject.keywordPlus | MESSENGER-RNA | - |
dc.subject.keywordPlus | VISCERAL FAT | - |
dc.subject.keywordPlus | RAT | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordAuthor | glucose uptake | - |
dc.subject.keywordAuthor | glucose transporter-1 | - |
dc.subject.keywordAuthor | protein kinase B | - |
dc.subject.keywordAuthor | profibrotic molecule | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.